FINWIRES · TerminalLIVE
FINWIRES

UOB Kay Hian Downgrades CSPC Pharmaceutical Group to Sell from Hold; Price Target is HK$6

By

CSPC Pharmaceutical Group (HKG:1093) has an average rating of overweight and mean price target of HK$12.05, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles